Progress and Indication for Use of Continuous Glucose Monitoring in Patients with Diabetes in Pregnancy: a Review

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2023 Sep 8

PMID 37680884

Authors

Yu Song

Xiaodan Zhai

Yu Bai

Cong Liu

Le Zhang

Affiliations

Soon will be listed here.

Abstract

Gestational diabetes mellitus is one of the most common endocrine diseases that occur during pregnancy. Disorders of blood glucose metabolism during pregnancy can increase the risk of adverse pregnancy outcomes, such as pregnancy-related hypertension, preeclampsia, eclampsia, miscarriage, macrosomia, and neonatal hypoglycemia. Continuous glucose monitoring (CGM) can safely and effectively monitor blood glucose changes in patients with gestational hyperglycemia, thereby reducing adverse pregnancy outcomes. Hence, this article aimed to provide a comprehensive review of the progress and indications for using CGM in pregnant patients with diabetes. CGM can reduce blood glucose fluctuations and the occurrence of serious hypoglycemia and hyperglycemia events and can provide time in range (TIR). TIR is an important indicator of blood glucose level. Patients with a higher TIR during pregnancy have better gestational outcomes.

References

Bolinder J, Antuna R, Geelhoed-Duijvestijn P, Kroger J, Weitgasser R . Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet. 2016; 388(10057):2254-2263. DOI: 10.1016/S0140-6736(16)31535-5. View

Preau Y, Galie S, Schaepelynck P, Armand M, Raccah D . Benefits of a Switch from Intermittently Scanned Continuous Glucose Monitoring (isCGM) to Real-Time (rt) CGM in Diabetes Type 1 Suboptimal Controlled Patients in Real-Life: A One-Year Prospective Study . Sensors (Basel). 2021; 21(18). PMC: 8473395. DOI: 10.3390/s21186131. View

Ornoy A, Becker M, Weinstein-Fudim L, Ergaz Z . Diabetes during Pregnancy: A Maternal Disease Complicating the Course of Pregnancy with Long-Term Deleterious Effects on the Offspring. A Clinical Review. Int J Mol Sci. 2021; 22(6). PMC: 7999044. DOI: 10.3390/ijms22062965. View

Haskova A, Radovnicka L, Petruzelkova L, Parkin C, Grunberger G, Horova E . Real-time CGM Is Superior to Flash Glucose Monitoring for Glucose Control in Type 1 Diabetes: The CORRIDA Randomized Controlled Trial. Diabetes Care. 2020; 43(11):2744-2750. PMC: 7576432. DOI: 10.2337/dc20-0112. View

Monnier L, Colette C, Wojtusciszyn A, Dejager S, Renard E, Molinari N . Toward Defining the Threshold Between Low and High Glucose Variability in Diabetes. Diabetes Care. 2017; 40(7):832-838. DOI: 10.2337/dc16-1769. View

Norgaard S, Mathiesen E, Norgaard K, Ringholm L . Comparison of Glycemic Metrics Measured Simultaneously by Intermittently Scanned Continuous Glucose Monitoring and Real-Time Continuous Glucose Monitoring in Pregnant Women with Type 1 Diabetes. Diabetes Technol Ther. 2021; 23(10):665-672. DOI: 10.1089/dia.2021.0109. View

Mariotti C, Giovannini A, Reibaldi M, Nicolai M, Saitta A . 25-gauge vitrectomy combined with half-fluence photodynamic therapy for the treatment of juxtapapillary retinal capillary hemangioma: a case report. Case Rep Ophthalmol. 2014; 5(2):162-7. PMC: 4067723. DOI: 10.1159/000363564. View

Jones L, Ray A, Moy F, Buckley B . Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes. Cochrane Database Syst Rev. 2019; 5:CD009613. PMC: 6532756. DOI: 10.1002/14651858.CD009613.pub4. View

. 2. Classification and Diagnosis of Diabetes: . Diabetes Care. 2019; 43(Suppl 1):S14-S31. DOI: 10.2337/dc20-S002. View

10.

Beck R, Bergenstal R, Riddlesworth T, Kollman C, Li Z, Brown A . Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials. Diabetes Care. 2018; 42(3):400-405. PMC: 6905478. DOI: 10.2337/dc18-1444. View

11.

Kudva Y, Ahmann A, Bergenstal R, Gavin 3rd J, Kruger D, Midyett L . Approach to Using Trend Arrows in the FreeStyle Libre Flash Glucose Monitoring Systems in Adults. J Endocr Soc. 2018; 2(12):1320-1337. PMC: 6243139. DOI: 10.1210/js.2018-00294. View

12.

Nakhleh A, Shehadeh N . Hypoglycemia in diabetes: An update on pathophysiology, treatment, and prevention. World J Diabetes. 2022; 12(12):2036-2049. PMC: 8696639. DOI: 10.4239/wjd.v12.i12.2036. View

13.

Jensen D, Korsholm L, Ovesen P, Beck-Nielsen H, Moelsted-Pedersen L, Westergaard J . Peri-conceptional A1C and risk of serious adverse pregnancy outcome in 933 women with type 1 diabetes. Diabetes Care. 2009; 32(6):1046-8. PMC: 2681038. DOI: 10.2337/dc08-2061. View

14.

Beck R, Bergenstal R, Cheng P, Kollman C, Carlson A, Johnson M . The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1c. J Diabetes Sci Technol. 2019; 13(4):614-626. PMC: 6610606. DOI: 10.1177/1932296818822496. View

15.

Guerin A, Nisenbaum R, Ray J . Use of maternal GHb concentration to estimate the risk of congenital anomalies in the offspring of women with prepregnancy diabetes. Diabetes Care. 2007; 30(7):1920-5. DOI: 10.2337/dc07-0278. View

16.

Majewska A, Stanirowski P, Wielgos M, Bomba-Opon D . Flash glucose monitoring in gestational diabetes mellitus: study protocol for a randomised controlled trial. BMJ Open. 2021; 11(3):e041486. PMC: 7929891. DOI: 10.1136/bmjopen-2020-041486. View

17.

Hawkins J . Glucose monitoring during pregnancy. Curr Diab Rep. 2010; 10(3):229-34. PMC: 2856850. DOI: 10.1007/s11892-010-0111-9. View

18.

Slattery D, Choudhary P . Clinical Use of Continuous Glucose Monitoring in Adults with Type 1 Diabetes. Diabetes Technol Ther. 2017; 19(S2):S55-S61. PMC: 5444504. DOI: 10.1089/dia.2017.0051. View

19.

Hong J, Fadzleeyanna M, Omar S, Tan P . HbA1c at term delivery and adverse pregnancy outcome. BMC Pregnancy Childbirth. 2022; 22(1):679. PMC: 9440566. DOI: 10.1186/s12884-022-05000-7. View

20.

Garcia-Moreno R, Benitez-Valderrama P, Barquiel B, Perez-de-Villar N, Hillman N, Pablos D . Efficacy of continuous glucose monitoring on maternal and neonatal outcomes in gestational diabetes mellitus: a systematic review and meta-analysis of randomized clinical trials. Diabet Med. 2021; 39(1):e14703. DOI: 10.1111/dme.14703. View